fda semaglutide shortage lawsuit Drug compounders sue over declaration ending Wegovy Novo Nordisk is suing U.S.

The manufacturer Novo Nordisk limited the supply (in May 2023) of lower doses of semaglutide to meet the needs of patients already taking semaglutide

Document dose, date, and injection site to maintain consistency and track rotation

[1] [2] However, longstanding neurological complications, such as peripheral neuropathy or cognitive changes, may require three to six months of consistent treatment before significant improvement occurs, and some damage may be irreversible if treatment is delayed

"So you end up going back to a higher fat mass and a lower muscle mass

Tirzepatide is available under two FDA-approved brand names: Mounjaro for type 2 diabetes and Zepbound for chronic weight management